291 related articles for article (PubMed ID: 23283638)
1. Recombinant vaccine displaying the loop-neutralizing determinant from protective antigen completely protects rabbits from experimental inhalation anthrax.
Oscherwitz J; Yu F; Jacobs JL; Cease KB
Clin Vaccine Immunol; 2013 Mar; 20(3):341-9. PubMed ID: 23283638
[TBL] [Abstract][Full Text] [Related]
2. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
Oscherwitz J; Feldman D; Yu F; Cease KB
Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
[TBL] [Abstract][Full Text] [Related]
3. A heterologous helper T-cell epitope enhances the immunogenicity of a multiple-antigenic-peptide vaccine targeting the cryptic loop-neutralizing determinant of Bacillus anthracis protective antigen.
Oscherwitz J; Yu F; Cease KB
Infect Immun; 2009 Dec; 77(12):5509-18. PubMed ID: 19805525
[TBL] [Abstract][Full Text] [Related]
4. A synthetic peptide vaccine directed against the 2ß2-2ß3 loop of domain 2 of protective antigen protects rabbits from inhalation anthrax.
Oscherwitz J; Yu F; Cease KB
J Immunol; 2010 Sep; 185(6):3661-8. PubMed ID: 20696862
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
[TBL] [Abstract][Full Text] [Related]
6. Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.
Oscherwitz J; Quinn CP; Cease KB
Vaccine; 2015 May; 33(20):2342-6. PubMed ID: 25820066
[TBL] [Abstract][Full Text] [Related]
7. A plant-produced protective antigen vaccine confers protection in rabbits against a lethal aerosolized challenge with Bacillus anthracis Ames spores.
Chichester JA; Manceva SD; Rhee A; Coffin MV; Musiychuk K; Mett V; Shamloul M; Norikane J; Streatfield SJ; Yusibov V
Hum Vaccin Immunother; 2013 Mar; 9(3):544-52. PubMed ID: 23324615
[TBL] [Abstract][Full Text] [Related]
8. Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.
Suryanarayana N; Verma M; Thavachelvam K; Saxena N; Mankere B; Tuteja U; Hmuaka V
Appl Microbiol Biotechnol; 2016 Oct; 100(19):8439-51. PubMed ID: 27364624
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptide vaccine targeting a cryptic neutralizing epitope in domain 2 of Bacillus anthracis protective antigen.
Oscherwitz J; Yu F; Jacobs JL; Liu TH; Johnson PR; Cease KB
Infect Immun; 2009 Aug; 77(8):3380-8. PubMed ID: 19487468
[TBL] [Abstract][Full Text] [Related]
10. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel multiepitope chimeric vaccine against anthrax.
Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R
Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
[TBL] [Abstract][Full Text] [Related]
12. Presentation of peptides from Bacillus anthracis protective antigen on Tobacco Mosaic Virus as an epitope targeted anthrax vaccine.
McComb RC; Ho CL; Bradley KA; Grill LK; Martchenko M
Vaccine; 2015 Nov; 33(48):6745-51. PubMed ID: 26514421
[TBL] [Abstract][Full Text] [Related]
13. A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.
Hermanson G; Whitlow V; Parker S; Tonsky K; Rusalov D; Ferrari M; Lalor P; Komai M; Mere R; Bell M; Brenneman K; Mateczun A; Evans T; Kaslow D; Galloway D; Hobart P
Proc Natl Acad Sci U S A; 2004 Sep; 101(37):13601-6. PubMed ID: 15342913
[TBL] [Abstract][Full Text] [Related]
14. Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.
Peachman KK; Rao M; Alving CR; Burge R; Leppla SH; Rao VB; Matyas GR
Infect Immun; 2006 Jan; 74(1):794-7. PubMed ID: 16369043
[TBL] [Abstract][Full Text] [Related]
15. Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates.
Yan M; Roehrl MH; Basar E; Wang JY
Vaccine; 2008 Feb; 26(7):947-55. PubMed ID: 18192092
[TBL] [Abstract][Full Text] [Related]
16. Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.
Osorio M; Wu Y; Singh S; Merkel TJ; Bhattacharyya S; Blake MS; Kopecko DJ
Infect Immun; 2009 Apr; 77(4):1475-82. PubMed ID: 19179420
[TBL] [Abstract][Full Text] [Related]
17. Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.
Bielinska AU; Janczak KW; Landers JJ; Makidon P; Sower LE; Peterson JW; Baker JR
Infect Immun; 2007 Aug; 75(8):4020-9. PubMed ID: 17502384
[TBL] [Abstract][Full Text] [Related]
18. Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.
Leffel EK; Bourdage JS; Williamson ED; Duchars M; Fuerst TR; Fusco PC
Clin Vaccine Immunol; 2012 Aug; 19(8):1158-64. PubMed ID: 22695155
[TBL] [Abstract][Full Text] [Related]
19. Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.
Stokes MG; Titball RW; Neeson BN; Galen JE; Walker NJ; Stagg AJ; Jenner DC; Thwaite JE; Nataro JP; Baillie LW; Atkins HS
Infect Immun; 2007 Apr; 75(4):1827-34. PubMed ID: 17145938
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel chimeric PA-LF antigen of Bacillus anthracis, its immunological characterization and evaluation as a future vaccine candidate in mouse model.
Varshney A; Kumar M; Nagar DP; Pal V; Goel AK
Biologicals; 2019 Sep; 61():38-43. PubMed ID: 31416791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]